The global casein glycomacropeptide (CGMP) market is set for steady growth, with valuation expected to rise from USD 126.4 million in 2025 to USD 215.9 million by 2035. According to industry analysis, the market will expand at a CAGR of 5.5% over the forecast period, fueled by increasing demand for functional food ingredients, medical nutrition solutions, and infant formula enhancements.

Market Drivers Fueling Growth

The rising awareness of protein-based functional ingredients is one of the primary forces propelling the CGMP market. With its unique bioactive properties and minimal phenylalanine content, CGMP is emerging as a key ingredient for phenylketonuria (PKU) patients, offering safe and digestible protein alternatives.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2651

Growing demand in sports nutrition and dietary supplements is also contributing to expansion. The inclusion of CGMP in clinical nutrition formulas strengthens gut health, supports immune modulation, and enhances recovery in athletes and patients alike. Moreover, the infant formula sector is witnessing notable adoption, where CGMP acts as a building block for safe and advanced nutritional blends.

The trend of personalized nutrition further boosts market prospects, as healthcare practitioners and consumers increasingly prefer tailored dietary solutions for metabolic and lifestyle-related health conditions.

Competitive Landscape

The CGMP market is moderately consolidated, with a mix of global leaders and regional players striving to expand their market presence through innovation, collaborations, and regulatory compliance. Key industry participants include:

• Arla Food Ingredients – A global leader in dairy-based ingredients, Arla is investing in high-purity CGMP solutions for medical nutrition and specialty foods.
• GL Biochem Ltd. – Specializing in advanced biochemical ingredients, GL Biochem is actively working on scaling CGMP applications in dietary supplements.
• S A Pharmachem Pvt. Ltd. – With a strong footprint in nutraceutical ingredients, the company is diversifying into CGMP-based formulations for clinical nutrition.
• Agropur Ingredients – Leveraging its dairy innovation expertise, Agropur is focusing on functional protein applications, including CGMP for specialized health solutions.

Competitive strategies revolve around product purity, bioactivity retention, and regulatory approvals, with companies investing in R&D for therapeutic nutrition and global supply chain integration.

Recent Development

In April 2025, Food Standards Australia New Zealand (FSANZ) authorized the use of milk fat globule membrane (MFGM) as a nutritional ingredient in baby formula. This milestone, once formally approved by the Food Ministers Meeting of Australia and New Zealand, will pave the way for greater acceptance of dairy-derived bioactive components, including CGMP, in early-life nutrition. The decision is expected to influence manufacturers to innovate with CGMP-enriched formulations, further widening market opportunities.

Browse Full Report: https://www.factmr.com/report/2651/casein-glycomacropeptide-market

Regional Insights

• North America remains a dominant region, with growing investments in medical nutrition products and advanced dietary solutions. The increasing prevalence of PKU patients in the U.S. and Canada is driving targeted product development.
• Europe continues to lead in innovation, supported by stringent quality standards and demand for natural, dairy-derived functional proteins. Regulatory approvals in the region are expected to accelerate adoption across infant formula and dietary supplements.
• Asia-Pacific is projected to witness the fastest growth, driven by rising disposable incomes, urbanization, and a surging infant formula industry in countries like China, India, and Japan. Increasing healthcare awareness also positions the region as a key growth hub for CGMP in clinical nutrition.

Future Outlook

As consumers seek science-backed functional ingredients, the global CGMP market is poised for sustainable expansion. Companies are expected to focus on precision fermentation, advanced purification processes, and partnerships with pharmaceutical firms to unlock new clinical and nutritional applications.

The ongoing integration of CGMP into infant formula, functional beverages, and dietary supplements underlines its importance in the evolving nutritional landscape. By 2035, CGMP is expected to become a mainstream ingredient in therapeutic and preventive health solutions, reshaping the global protein ingredients market.